biomarin
BioMarin is a global biotechnology company focused on translating genetic discoveries into medicines, with a strong emphasis on science innovation and creating therapies for genetic conditions. Their Technical Operations group supports manufacturing, quality assurance, and regulatory compliance to produce drugs for clinical and commercial use.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
12% below the average for this role
Part-Time Lecturer, Science and Graduate Courses for Biotechnology Graduate Program - Toronto
Northeastern University
Cell Process Development Co-op
Beam Therapeutics
Sr. Quality Assurance Specialist
Integrated Resources INC
Blood Cell Therapies Co-op
Beam Therapeutics
mRNA Science Intern
Beam Therapeutics
Intern
GSK plc